Yahoo India Web Search

Search results

    • Alumis raises $250m in IPO as biotech stock stirs

      Alumis raises $250m in IPO as biotech stock stirs

      Pharmaceutical Technology· 7 days ago

      A-005, also a TYK2 inhibitor, is in Phase I trial for uveitis, a type of eye inflammation. Alumis’ IPO closely follows a U-turn earlier this month taken...